The differences between the cell responses to MEK inhibitor and ATK inhibitor treatment support the notion that the MAPK, not the PI3K/AKT signaling, plays a functionally important role in DNA damage repair in the breast cancer cells. Here, AKT1 is linked to breast carcinoma.